Aralez Pharm Inc (ARLZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARLZ | FNCH | CYTO | ||
| Company | Aralez Pharm Inc | Finch Therapeutics Group Inc | Altamira Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.04 | 2.11 | 1.8500 | ||
| High | 0.04 | 2.19 | 2.4699 | ||
| Low | 0.03 | 1.95 | 1.6000 | ||
| Last | 0.03 | 1.98 | 1.7100 | ||
| Change | -0.01 | -0.15 | +0.2800 | ||
| % Change | -15.00% | -7.04% | +19.58% | ||
| Volume | 6,765,800 | 93,800 | 51,737,703 | ||
| 20-Day Average Volume | 5,195,370 | 51,370 | 2,636,850 | ||
| Previous Close | 0.04 | 2.13 | 1.4300 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.22 | 2.15 | 1.5500 | ||
| 20-Day Raw Stochastic | 2.17% | 14.10% | 28.97% | ||
| 20-Day Relative Strength | 27.93% | 44.90% | 52.03% | ||
| Weighted Alpha | -83.82 | -76.53 | -87.77 | ||
| Today's Opinion | N/A | 100% Sell | 64% Sell | ||
| Previous Opinion | N/A | 100% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 96% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -47.69% since 08/13/18 | +3.13% since 05/16/24 | +9.62% since 05/16/24 | ||
| Low | 0.03 on 08/20/18 | 1.92 on 05/17/24 | 1.4300 on 05/22/24 | ||
| High | 0.08 on 08/14/18 | 2.45 on 05/20/24 | 2.4699 on 05/23/24 | ||
| 1-Month | |||||
| %Chg | -89.21% since 07/20/18 | -29.00% since 04/23/24 | +8.23% since 04/23/24 | ||
| Low | 0.03 on 08/20/18 | 1.87 on 05/13/24 | 1.3500 on 04/25/24 | ||
| High | 0.44 on 07/24/18 | 2.65 on 05/06/24 | 2.4699 on 05/23/24 | ||
| 3-Month | |||||
| %Chg | -91.81% since 05/18/18 | -18.18% since 02/23/24 | -5.00% since 02/23/24 | ||
| Low | 0.03 on 08/20/18 | 1.86 on 04/12/24 | 1.3500 on 04/25/24 | ||
| High | 0.51 on 06/13/18 | 4.46 on 03/11/24 | 3.4900 on 03/25/24 | ||
| 6-Month | |||||
| %Chg | -97.91% since 02/20/18 | -46.49% since 11/22/23 | -71.40% since 11/22/23 | ||
| Low | 0.03 on 08/20/18 | 1.86 on 04/12/24 | 1.3500 on 04/25/24 | ||
| High | 2.09 on 03/12/18 | 5.70 on 12/01/23 | 17.2000 on 11/30/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,284 | 3,420 | 2,256 | ||
| Shares Outstanding, K | 67,190 | 1,606 | 1,578 | ||
| Annual Sales | 105,950,000 | 110,000 | 0 | ||
| Annual Net Income | -125,210,000 | -74,750,000 | -4,310,000 | ||
| Last Quarter Sales | 38,080,000 | 0 | 0 | ||
| Last Quarter Net Income | -19,740,000 | -3,880,000 | -3,690,866 | ||
| 60-Month Beta | 1.20 | 0.46 | 1.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/09/17 | -2.41 on 05/10/24 | N/A | ||
| Latest Earnings Date | 08/22/18 | 05/08/24 | 07/10/24 | ||
| Most Recent Dividend | 1.750 on 12/31/13 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||